Keywords
Cancer immunotherapyImmunotherapyClinical trialCancerChimeric antigen receptorTumor immunologyBench to bedsideMedicineImmune checkpointImmunologyImmune systemBiologyBioinformaticsInternal medicine
Affiliated Institutions
Related Publications
Cancer immunotherapy using checkpoint blockade
The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...
The biologic importance of tumor‐infiltrating lymphocytes
Detailed pathologic analysis has delineated a close association between intratumoral CD 8 + cytotoxic T cells and favorable clinical outcomes in diverse cancers. Conversely, the...
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Cancer treatment by immune checkpoint blockade (ICB) can bring long-lasting clinical benefits, but only a fraction of patients respond to treatment. To predict ICB response, we ...
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Anti-PD-1 antibody produced objective responses in approximately one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse...
Understanding the tumor immune microenvironment (TIME) for effective therapy
The clinical successes in immunotherapy have been both astounding and at the same time unsatisfactory. Countless patients with varied tumor types have seen pronounced clinical r...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 20
- Issue
- 11
- Pages
- 651-668
- Citations
- 3841
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
3841
OpenAlex
Cite This
Alex D. Waldman,
Jill M. Fritz,
Michael J. Lenardo
(2020).
A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Nature reviews. Immunology
, 20
(11)
, 651-668.
https://doi.org/10.1038/s41577-020-0306-5
Identifiers
- DOI
- 10.1038/s41577-020-0306-5